☰

Ryan L. Bjordahl, Ph.D. - Publications

Affiliations: 
2011 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Cell Biology, Physiology Biology
Tree Info Grants Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Snyder KM, Dixon KJ, Davis Z, Hosking M, Hart G, Khaw M, Matson A, Bjordahl R, Hancock B, Shirinbak S, Miller JS, Valamehr B, Wu J, Walcheck B. iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting. Journal For Immunotherapy of Cancer. 11. PMID 38056893 DOI: 10.1136/jitc-2023-007280  0.551
2023 Goulding J, Yeh WI, Hancock B, Blum R, Xu T, Yang BH, Chang CW, Groff B, Avramis E, Pribadi M, Pan Y, Chu HY, Sikaroodi S, Fong L, Brookhouser N, ... ... Bjordahl R, et al. A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors. Med (New York, N.Y.). PMID 37172578 DOI: 10.1016/j.medj.2023.04.004  0.525
2022 Cichocki F, Bjordahl R, Goodridge JP, Mahmood S, Gaidarova S, Abujarour R, Davis ZB, Merino A, Tuininga K, Wang H, Kumar A, Groff B, Witty A, Bonello G, Huffman J, et al. Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma. Nature Communications. 13: 7341. PMID 36446823 DOI: 10.1038/s41467-022-35127-2  0.5
2022 Cichocki F, Goodridge J, Bjordahl R, Mahmood S, Davis ZB, Gaidarova S, Abujarour R, Groff B, Witty AD, Wang H, Tuininga K, Kodal B, Felices M, Bonello GB, Huffman J, et al. Dual-antigen targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia. Blood. PMID 35917442 DOI: 10.1182/blood.2021015184  0.641
2021 Woan KV, Kim H, Bjordahl R, Davis ZB, Gaidarova S, Goulding J, Hancock B, Mahmood S, Abujarour R, Wang H, Tuininga K, Zhang B, Wu CY, Kodal B, Khaw M, et al. Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy. Cell Stem Cell. PMID 34525347 DOI: 10.1016/j.stem.2021.08.013  0.511
2021 Chiu E, Felices M, Cichocki F, Davis Z, Wang H, Tuninga K, Vallera DA, Lee T, Bjordahl R, Malmberg KJ, Valamehr B, Miller JS. Anti-NKG2C/IL-15/anti-CD33 Killer Engager Directs Primary and iPSC-derived NKG2C NK cells to Specifically Target Myeloid Leukemia. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34174441 DOI: 10.1016/j.ymthe.2021.06.018  0.627
2020 Cichocki F, Bjordahl R, Gaidarova S, Mahmood S, Abujarour R, Wang H, Tuininga K, Felices M, Davis ZB, Bendzick L, Clarke R, Stokely L, Rogers P, Ge M, Robinson M, et al. iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy. Science Translational Medicine. 12. PMID 33148626 DOI: 10.1126/scitranslmed.aaz5618  0.608
2019 Zhu H, Blum R, Bjordahl R, Gaidarova S, Rogers P, Lee TT, Abujarour R, Bonello GB, Wu J, Tsai PF, Miller JS, Walcheck B, Valamehr B, Kaufman DS. Pluripotent stem cell-derived NK cells with high-affinity non-cleavable CD16a mediate improved anti-tumor activity. Blood. PMID 31856277 DOI: 10.1182/Blood.2019000621  0.631
2017 Cichocki F, Valamehr B, Bjordahl R, Zhang B, Rezner B, Rogers P, Gaidarova S, Moreno SK, Tuininga K, Dougherty P, McCullar V, Howard P, Sarhan D, Taras E, Schlums H, et al. GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity. Cancer Research. PMID 28790065 DOI: 10.1158/0008-5472.Can-17-0799  0.559
2013 Å edý JR, Bjordahl RL, Bekiaris V, Macauley MG, Ware BC, Norris PS, Lurain NS, Benedict CA, Ware CF. CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells. Journal of Immunology (Baltimore, Md. : 1950). 191: 828-36. PMID 23761635 DOI: 10.4049/jimmunol.1300894  0.581
2013 Bjordahl RL, Steidl C, Gascoyne RD, Ware CF. Lymphotoxin network pathways shape the tumor microenvironment. Current Opinion in Immunology. 25: 222-9. PMID 23339845 DOI: 10.1016/j.coi.2013.01.001  0.315
2007 Humann J, Bjordahl R, Andreasen K, Lenz LL. Expression of the p60 autolysin enhances NK cell activation and is required for listeria monocytogenes expansion in IFN-gamma-responsive mice. Journal of Immunology (Baltimore, Md. : 1950). 178: 2407-14. PMID 17277147 DOI: 10.4049/Jimmunol.178.4.2407  0.413
Show low-probability matches.